Pensions reform – The most important thing?

09 Mar 2010
Few people are making sufficient preparations for their retirement and the government hopes reforms to pension schemes will prevent mass poverty. Diana Spencer takes a look at the proposed reforms and how the pharma industry shapes up in this area. Read More

The journey to Pharma 2.0

02 Dec 2009
Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused by the economic downturn and President Obama's planned overhaul of the US healthcare system. To continue on its journey towards 'Pharma 2.0', the industry must balance the more pressing short-term issues against longer-term trends. Read More

Weighing up value – Identification of your key accounts

23 Oct 2009
Key Account Management might be an effective way of approaching your business, but it certainly isn’t a quick fix. Management Consultant Joanna Allen explains how to go about identifying your key accounts. Read More

“We’re letting you go” – How to break bad news effectively

08 Oct 2009
Recent M&A activity highlights the continuing contraction of the pharma industry worldwide. One of the most uncomfortable tasks a manager will face during this recession will be making an employee redundant. Louise Crowley offers some simple tips on how to deliver bad news without making matters worse. Read More

Budgeting for radical change

30 Sep 2009
Budget cuts could bring an acceleration in the adoption of private sector service providers. Mike Sobanja and Andy Etheridge ask whether the industry has the skills to influence these new customers. Read More

Dispute resolution: Can the new guidelines keep the peace?

15 Sep 2009
Do the latest changes to dispute resolution procedures represent a return to the good old days or just a cost-cutting exercise? Pf’s Diana Spencer investigates. Read More

The Private Sector and the NHS

04 Sep 2009
The demands of world-class commissioning will mean increased collaboration between the NHS and the private sector. To stay ahead of the game, pharma companies need to be engaging with the private sector on a local level, argue Duncan Alexander and Mike Sobanja. Read More

Key Account Management – Challenges for the Industry

26 Aug 2009
It is now widely accepted that ‘one size fits all’ is no longer relevant in the modern NHS and that key account management is the way forward. But how do companies and individuals need to change to make KAM a success? Management Consultant Joanna Allen explains. Read More

Asserting the value of pharma – ABPI Annual Report 2008/09

21 Aug 2009
The ABPI Annual Report 2008/09 provides an update on the activities of the Association over the past year, as well as the challenges and successes of the industry as a whole and plans for the future. Read More

Budget’s price cuts are bad news for branded pharmaceuticals

11 Aug 2009
The Pharmaceutical Price Regulation Scheme (PPRS) will cut branded drug sales by £550m ($800m) during 2010–11. Datamonitor pharmaceutical strategy analyst Alistair Sinclair comments. Read More